PMV Tina Fund
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
About
The fund's activity peaked in 2013. In terms of the fund's performance, this VC has the average number of exits. Deals in the range of 10 - 50 millions dollars are most common for this fund. The highest number of exits from this fund were in 2015. The fund generally invests in less than 2 deals every year. PMV Tina Fund is involved in 9 percentage points less than the average amount of lead investments when compared with other funds.
Among the most popular investment industries for the fund are Manufacturing, Advanced Materials. However, the fund’s focus is not limited to this, since there are 6 more areas of investment. The fund has specific requirements for the number of founders in a start-up. Moreover, a start-up needs to be 6-10 years old to get investment from this fund. FRX Polymers, Luxexcel, Biocartis are among the most popular portfolio start-ups of the fund.
The usual method for the fund is to invest in rounds with 6-7 other investors. Besides PMV Tina Fund, start-ups are typically funded by Johnson & Johnson Development Corporation, Masdar Capital, Debiopharm Group and 8 more VCs. Other VCs who often invest in the same rounds are Johnson & Johnson Development Corporation, Valiance Asset Management, RMM, the total number of co-investors is 1. The investors in the following rounds are usually SET Ventures, PMV, Munich Venture Partners, and 1 VC in total.
Fund Activity
Not operative
Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]
Domain name: m12.vc; User name format in descending order of probability: first '.' last
Group Appearance [how often fund is operating separately from groups with shared interest]
100.0% of cases
Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]
20.0% of cases
Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]
x8
Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]
1.4 years
Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]
0.13 out of 1
Funds Investing in Previous
Rounds
Johnson & Johnson Development Corporation, Masdar Capital, Debiopharm Group
Funds Investing Together
Johnson & Johnson Development Corporation, Valiance Asset Management, RMM
Funds Investing in Following
Rounds
If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.
Unicorn Nest finds the most relevant investors for startups.
Tell us about your startup and get the list of VCs most likely to invest in your next round.
Find your perfect investor now
- No reviews are submitted yet.
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Complain
To post a comment or write a complain, please sign in with LinkedIn
